Expression of xenobiotic metabolizing genes in head and neck cancer tissues

Asian Pacific Journal of Cancer Prevention

Volumn 12, Issue 2, 2011, Pages 377-382

  Masood, Nosheen ^a   Malik, Fraz Arshad ^a   Kayani, Mahmood Akhtar ^a  

^a Department of Electrical Computer Engineering   (Pakistan)

Author keywords

CYP1A1; Expression; GSTM1; GSTP1; GSTT1; Head and neck cancers; mRNA

Indexed keywords

EID: 79958781208     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. Antoun G, Baylin SB, Ali-Osman F (2000). DNA methyltransferase levels and altered CpG methylation in the total genome and in the GSTP1 gene in human glioma cells transfected with sense and antisense DNA methyltransferase cDNA. J Cell Biochem, 77, 372-1.
2. Anttila S, Tuominen P, Hirvonen A, et al (2001). CYP1A1 levels in lung tissue of tobacco smokers and polymorphisms of CYP1A1 and aromatic hydrocarbon receptor. Pharmacogenetics, 11, 501-9.
3. Bartsch DK, Schilling T, Ramaswamy A, et al (2000). Management of nonfunctioning islet cell carcinomas. World J Surg, 24, 1418-4.
4. Bentz BG, Haines GK, Radosevich JA (2000). Glutathione S-transferase pi in squamous cell carcinoma of the head and neck. Laryngoscope, 110, 1642-7.
5. Chang TJ, Chang H, Chen P, et al (2007). Requirement of aryl hydrocarbon receptor overexpression for CYP1B1 upregulation and cell growth in human lung adenocarcinomas. Clin Cancer Res, 13, 38-5.
6. Chasseaud LF (1979). The role of glutathione and glutathione S-transferases in the metabolism of chemical carcinogens and other electrophilic agents. Adv Cancer Res, 29, 175-4.
7. Chen YK, Lin LM (1995). Immunohistochemical demonstration of epithelial glutathione S-transferase isoenzymes in normal, benign, premalignant and malignant human oral mucosa. J Oral Pathol Med, 24, 316-1.
8. Conway DE, Sakurai Y, Weiss D, et al (2009). Expression of CYP1A1 and CYP1B1 in human endothelial cells, regulation by fluid shear stress. Cardiovasc Res, 81, 669-7.
9. David GB, Isabelle M, Jonathan H (2007). Glutathione S transferase, differential expression of alpha, mu and pi isoenzymes in benign prostate, prostatic intraepithelial neoplasia, and prostatic adenocarcinoma. Human Pathology, 38, 1394-1.
10. Diemut KG, Herbert R, Uta W, et al (2004). Genotype and phenotype of glutathione S transferase in patients with head and neck carcinoma. Otolaryngol Head Neck Surg, 130, 718- 5.
11. El-Rayes BF, Ali S, Heilbrun LK, et al (2003). Cytochrome p450 and glutathione transferase expression in human breast cancer. Clin Cancer Res, 9, 1705-9.
12. Farin FM, Bigler LG, Oda D, et al (1995). Expression of cytochrome P450 and microsomal exposide hydrolase in cervical and oral epithelial cells immortalized by human papillomavirus type 16 E6/E7 genes. Carcinogenesis, 16, 1670-1.
13. Fusako N, Eriko K, Hiro-omi T (2004). Oxidative stress induces GSTP1 and CYP3A4 expression in the human erythroleukemia cell lines, K562. Biol Pharm Bull, 27, 492-5.
14. Gelboin HV (1980). Benzo [alpha] pyrene metabolism, activation and carcinogenesis, role and regulation of mixed-function oxidases and related enzymes. Physiol Rev, 60, 1107-6.
15. Gonzalez FJ, Gelboin HV (1994). Role of human cytochromes P450 in the metabolic activation of chemical carcinogens and toxins. Drug Metab Rev, 26, 165-3.
16. Hayes JD, Pulford DJ (1995). The glutathione S-transferase supergene family, regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. Crit Rev Biochem Mol Biol, 30, 445-50.
17. Hildebrandt AG, Bergs C, Heinemeyer G, et al (1981). Studies on the mechanism of stimulation of microsomal H2O2 formation and benzo(a)pyrene hydroxylation by substrates and flavone. Adv. Exp. Med. Biol., 136A, 179-8.
18. Holley SL, Fryer AA, Haycock JW, et al (2007). Differential effects of glutathione S-transferase pi (GSTP1) haplotypes on cell proliferation and apoptosis. Carcinogenesis, 28, 2268-3.
19. Ioanna AD, Demetrios AA, Demetrios AS (2001). Genetic polymorphisms and transcriptional pattern analysis od CYP1A1, AhR, GSTM1, GSTP1 and GSTT1 genes in breast cancer. Int J Mol Med, 8, 79-7.
20. Isabel S, Klaus J, Philipp S, et al (2010). Gene promotet methylation and its potential relevance in early prostate cancer diagnosis. Pathobiol, 77, 260-6.
21. Lafuente A, Pujol F, Carretero P, et al (1993). Human glutathione S-transferase mu (GST mu) deficiency as a marker for the susceptibility to bladder and larynx cancer among smokers. Cancer Lett, 68, 49-4.
22. Lafuente A, Molina R, Palou J, et al (1995). Phenotype of glutathione S-transferase mu (GSTM1) and susceptibility to malignant melanoma, MMM (multidisciplinary malignant melanoma) group. Br J Cancer, 72, 324-6.
23. Lee WH, Isaacs WB, Bova GS, et al (1997). CG island methylation changes near the GSTP1 gene in prostatic carcinoma cells detected using the polymerase chain reaction, a new prostate cancer biomarker. Cancer Epidemiol Biomarkers Prev, 6, 443-50.
24. Lo HW, Ali-Osman F (1997). Genomic cloning of hGSTP1*C, an allelic human π class glutathione S-transferase gene variant and functional characterization of its retinoic acid response elements. J Biol Chem, 272, 32743-9.
25. Lo HW, Ali-Osman F (2002). Cyclic AMP mediated GSTP1 gene activation in tumor cells involves the interaction of activated CREB-1 with the GSTP1 CRE, a novel mechanism of cellular GSTP1 gene regulation. J Cell Biochem, 87, 103-6.
26. Matthias C, Bockmuhl U, Jahnke V, et al (1998). Polymorphism in cytochrome P450 CYP2D6, CYP1A1, CYP2E1 and glutathione S-transferase, GSTM1, GSTM3, GSTT1 and susceptibility to tobacco- related cancers, studies in upper aerodigestive tract cancers. Pharmacogenetics, 8, 91-0.
27. Matthias C, Bockmuhl U, Jahnke V, et al (1998). The glutathione-S-transferase GSTP1 polymorphism, effects on susceptibility to oral/pharyngeal and laryngeal carcinomas. Pharmacogenetics, 8, 1-6.
28. Matthias C, Jahnke V, Hand P, et al (1999). Immunohistologic and molecular genetic studies of the effect of glutathione-S-transferases on the development of squamous epithelial carcinomas in the area of the head-neck. Laryngorhino otologie, 78, 182-8.
29. Moffat GJ, McLaren AW, Wolf CR (1996). Sp1-mediated transcriptional activation of the human π class glutathione S-transferase promoter. J Biol Chem, 271, 1054-0.
30. Morel Y, Barouki R (1998). Down-regulation of cytochrome P450 1A1 gene promoter by oxidative stress, critical contribution of NFI. J Biol Chem, 273, 26969-6.
31. Morita S, Yano M, Tsujinaka T, et al (1999). Genetic polymorphisms of drug-metabolizing enzymes and susceptibility to head-and-neck squamous-cell carcinoma. Int J Cancer, 80, 685-8.
32. Mulder TPJ, Manni JJ, Roelofs HMJ, et al (1995). Glutathione S-transferases and glutathione in human head and neck cancer. Carcinogenesis, 16, 619-4.
33. Murray GI, Shaw D, Weaver RJ, et al (1994). Cytochrome P450 expression in oesophageal cancer. Gut, 35, 599-3.
34. Murray GI, Taylor VE, McKay JA, et al (1995). Expression of xenobiotic metabolizing enzymes in tumors of the urinary bladder. Int J Exp Pathol, 76, 271-6.
35. Nebert DW (1989). The Ah locus, genetic differences in toxicity, cancer, mutation and birth defects. Crit Rev Toxicol, 20, 153-4.
36. Niitsu Y, Takahashi Y, Saito T, et al (1989). Serum glutathione-S-transferase-pi as a tumor marker for gastrointestinal malignancies. Cancer, 63, 317-3.
37. Nosheen M, Ishrat M, Malik FA, et al (2010). Association of GSTM1 and GSTT1 gene deletions with risk of head and neck cancer in Pakistan- a case control study. Asian Pacific J Cancer Prev, 11, 1-6.
38. Paton TE, Renton KW (1998). Cytokine-mediated downregulation of CYP1A1 in Hepa1 cells. Biochem. Pharmacol., 55, 1791-6.
39. Pavek P, Dvorak Z (2008). Xenobiotic-induced transcriptional regulation of xenobiotic metabolizing enzymes of the cytochrome P450 superfamily in human extrahepatic tissues. Curr Drug Metab, 9, 129-3.
40. Pompon D, Perret A, Laine R, et al (1997). Molecular mechanism of modulation of the oxidative stress generated by uncoupling of the P450-dependant monooxygenases and related enzymes, controlling role of the global chemical environment. In Abstracts of the 1st International Workshop on Free Radicals in Liver Metabolism and Disease, Dinard, France. Université de Rennes I, Rennes, France.
41. Sato M, Sato T, Izumo T, et al (2000). Genetically high susceptibility to oral squamous cell carcinoma in terms of combined genotyping of CYP1A1 and GSTM1 genes. Oral Oncol, 36, 267-1.
42. Seidegard J, Pero RW, Miller DG, et al (1986). A glutathione transferase in human leukocytes as a marker for the susceptibility to lung cancer. Carcinogenesis, 7, 751-3.
43. Shea TC, Kelley SL, Henner WD (1988). Identification of an anionic form of glutathione transferase present in many human tumors and human tumor cell lines. Cancer Res, 48, 527-3.
44. Smart J, Daly AK (2000). Variation in induced CYP1A1 levels, relationship to CYP1A1, Ah receptor and GSTM1 polymorphisms. Pharmacogenetics, 10, 11-4.
45. Strange RC, Faulder CG, Davis BA, et al (1984). The human glutathione S-transferases, studies on the tissue distribution and genetic variation of the GST1, GST2 and GST3 isozymes. Ann Hum Genet, 48, 11-0.
46. Tanita J, Tsuchida S, Hozawa J, et al (1993). Expression of glutathione S-transferase-pi in human squamous cell carcinomas of the pharynx and larynx. Loss after radiation therapy. Cancer, 72, 569-6.
47. Theo PJ, Johannes JM, Hennie MJ, et al (1995). Glutathione S transferases and glutathione in human head and neck cancer. Carcinogenesis, 16, 619-4.
48. Tsuchida S (1990). Purification and characterization of glutathione transferases with an activity toward nitroglycerin from human aorta and heart, multiplicity of the human class mu forms. J Biol Chem, 265, 7150-7.
49. Tu CP, Weiss MJ, Li NQ, et al (1983). Tissue-specific expression of the rat glutathione S-transferases. J Biol Chem, 8, 4659-2.
50. Wandel C, Witte JS, Hall JM, et al (2000). CYP3A activity in African American and European American men, population differences and functional effect of the CYP3A4*1B5-promoter region polymorphism. Clin Pharmacol Ther, 68, 82-1.
51. Wang T, Arifoglu P, Ronai Z, et al (2001). Glutathione S-transferase P1-1 (GSTP1-1) inhibits c-Jun N-terminal kinase (JNK1) signaling through interaction with the C-terminus. J Biol Chem, 276, 20999-3.
52. Wei C, Caccavale RJ, Kehce JJ, et al (2001). CYP1A2 is expressed along with CYP1A1 in the human lung. Cancer Lett, 171, 113-0.
53. Whyatt RM, Garte SJ, Cosma GN, et al (1995). CYP1A1 mRNA levels in placental tissue as a biomarker of environmental exposure. Cancer Epidemiol Biomarkers Prev, 4, 147-3.
54. Xia C, Hu J, Ketterer B, et al (1996). The organization of the human GSTP1-1 gene promoter and its response to retinoic acid and cellular redox status. Biochem J, 313, 155-1.
55. Xu S, Wang Y, Roe B, et al (1998). Characterization of the human class mu glutathione S-transferase gene cluster and the GSTM1 deletion. J Biol Chem, 273, 3517-7.
56. Zhong LP, Zhao SF, Chen GF, et al (2006). Increased levels of CK19 mRNA in oral squamous cell carcinoma tissue detected by relative quantification with real-time polymerase chain reaction. Arch Oral Biol, 1, 1112-9.